<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It remains unclear whether surgical treatment of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-esophageal reflux disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) decreases the long-term risk of lower esophagus <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>; yet, proposed reductions in Barrett's epithelial transformation have been used as a rationale for antireflux surgery </plain></SENT>
<SENT sid="1" pm="."><plain>We report the case of a 63-year-old woman with a 40-year history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, whose symptoms returned after a Nissen fundoplication </plain></SENT>
<SENT sid="2" pm="."><plain>A gastroscopy done 3 years later revealed BE </plain></SENT>
<SENT sid="3" pm="."><plain>Despite close surveillance, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the lower esophagus was diagnosed 8 years after the original surgery </plain></SENT>
<SENT sid="4" pm="."><plain>Thus far, there is insufficient evidence to convince practitioners that surgery should be the first line of treatment to prevent malignant change in BE </plain></SENT>
<SENT sid="5" pm="."><plain>Further well-standardized, prospective trials are required </plain></SENT>
<SENT sid="6" pm="."><plain>Our case demonstrates that antireflux surgery in a patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and BE cannot be relied upon to prevent <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>